These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7363859)

  • 41. The preovulatory prolactin surge is prolonged by a progesterone-dependent dopaminergic mechanism.
    Arbogast LA; Ben-Jonathan N
    Endocrinology; 1990 Jan; 126(1):246-52. PubMed ID: 1967162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dopaminergic and serotonergic involvement in opiate-induced prolactin release in monkeys.
    Wehrenberg WB; McNicol D; Wardlaw SL; Frantz AG; Ferin M
    Endocrinology; 1981 Aug; 109(2):544-7. PubMed ID: 7250056
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stimulation in vivo of the secretion of prolactin and growth hormone by beta-endorphin.
    Rivier C; Vale W; Ling N; Brown M; Guillemin R
    Endocrinology; 1977 Jan; 100(1):238-41. PubMed ID: 187406
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Iontophoresis of morphine into the arcuate nucleus: effects on dopamine concentrations in hypophysial portal plasma and serum prolactin concentrations.
    Haskins JT; Gudelsky GA; Moss RL; Porter JC
    Endocrinology; 1981 Mar; 108(3):767-71. PubMed ID: 7460840
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunoreactive prolactin in the hypothalamus and cerebrospinal fluid of male and female rats.
    DeVito WJ
    Neuroendocrinology; 1989 Aug; 50(2):182-6. PubMed ID: 2779738
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum prolactin and growth hormone responses to naloxone and intracerebral ventricle morphine administration in heifers.
    Leshin LS; Rund LA; Thompson FN; Mahaffey MB; Chang WJ; Byerley DJ; Kiser TE
    J Anim Sci; 1990 Jun; 68(6):1656-65. PubMed ID: 2384365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term ACTH induced diminished responsiveness of prolactin secretion to morphine.
    Kanyicska B; Stark E; Horváth G; Simonyi A; Fekete MI
    Life Sci; 1983 Jul; 33(1):55-63. PubMed ID: 6306374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stimulatory control of prolactin by dopamine.
    Brown GM; Seggie JA
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):355-8. PubMed ID: 6891802
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of tubero-infundibular dopaminergic neurons on prolactin and alpha-melanocyte stimulating hormone release.
    Bedran-de-Castro JC; Petrovic SL; Khorram O; McCann SM
    Braz J Med Biol Res; 1991; 24(10):1059-62. PubMed ID: 1665725
    [TBL] [Abstract][Full Text] [Related]  

  • 50. p-Tyramine, a natural amine, inhibits prolactin release in vivo.
    Becú-Villalobos D; Lacau de Mengido IM; Libertun C
    Endocrinology; 1985 May; 116(5):2044-8. PubMed ID: 3987630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Possible involvement of the hypothalamic dopaminergic system in the prolactin-inhibitory effects of the pineal gland in blind-anosmic male rats.
    Leadem CA; Burns DM; Benson B
    Neuroendocrinology; 1988 Jul; 48(1):1-7. PubMed ID: 3173637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulating effect of the nootropic drug, piracetam on stress- and subsequent morphine-induced prolactin secretion in male rats.
    Matton A; Engelborghs S; Bollengier F; Finné E; Vanhaeist L
    Br J Pharmacol; 1996 Feb; 117(3):502-506. PubMed ID: 8821540
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypothalamic site of action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Russell DH; Buckley AR; Shah GN; Sipes IG; Blask DE; Benson B
    Toxicol Appl Pharmacol; 1988 Jul; 94(3):496-502. PubMed ID: 3400098
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In situ voltammetric microelectrodes: application to the measurement of median eminence catecholamine release during simulated suckling.
    Plotsky PM; De Greef WJ; Neill JD
    Brain Res; 1982 Nov; 250(2):251-62. PubMed ID: 7171989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Morphine can stimulate prolactin release independent of a dopaminergic mechanism.
    Shin SH; Obonsawin MC; Van Vugt DA; Baby N; Jhamandas K
    Can J Physiol Pharmacol; 1988 Nov; 66(11):1381-5. PubMed ID: 2907416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The participation of hypothalamic dopamine in morphine-induced prolactin release in man.
    Delitala G; Grossman A; Besser GM
    Clin Endocrinol (Oxf); 1983 Oct; 19(4):437-44. PubMed ID: 6627697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition by naloxone of the rise in hypothalamic dopamine and serum prolactin induced by ethanol.
    Seilicovich A; Rubio M; Duvilanski B; Muñoz Maines V; Rettori V
    Psychopharmacology (Berl); 1985; 87(4):461-3. PubMed ID: 3001809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Failure of opiates to reverse dopamine inhibition of prolactin secretion in vitro.
    Login IS; Macleod RM
    Eur J Pharmacol; 1979 Dec; 60(2-3):253-5. PubMed ID: 527660
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of salsolinol in the regulation of pituitary prolactin and peripheral dopamine release.
    Oláh M; Bodnár I; Daniel G; Tóth BE; Vecsernyés M; Nagy GM
    Reprod Med Biol; 2011 Sep; 10(3):143-151. PubMed ID: 29662355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of endogenous hyperprolactinaemia on opiate-induced behavioral changes in rats.
    Drago F; Scapagnini U
    Brain Res; 1985 Jun; 336(2):215-21. PubMed ID: 4005582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.